Aia Group LTD Biogen Inc. Transaction History

Aia Group LTD

$3.67 Billion
Q3 2024

A detailed history of Aia Group LTD transactions in Biogen Inc. stock. As of the latest transaction made, Aia Group LTD holds 1,411 shares of BIIB stock, worth $245,217. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,411

Previous 1,276 10.58%

Holding current value

$245,217

Previous $295,000 7.46%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$189.07 - $236.8 $25,524 - $31,968	135 Added 10.58%	1,411 $273,000
Q2 2024 Jul 31, 2024	SELL	$190.52 - $236.72 $35,817 - $44,503	-188 Reduced 12.84%	1,276 $295,000
Q1 2024 May 06, 2024	SELL	$212.02 - $267.71 $20,989 - $26,503	-99 Reduced 6.33%	1,464 $315,000
Q4 2023 Jan 31, 2024	SELL	$222.59 - $267.94 $31,385 - $37,779	-141 Reduced 8.27%	1,563 $404,000
Q3 2023 Nov 01, 2023	BUY	$253.3 - $285.89 $20,264 - $22,871	80 Added 4.93%	1,704 $437,000
Q2 2023 Jul 28, 2023	SELL	$275.25 - $318.06 $646,287 - $746,804	-2,348 Reduced 59.11%	1,624 $462,000
Q1 2023 Apr 28, 2023	SELL	$256.56 - $292.34 $51,312 - $58,467	-200 Reduced 4.79%	3,972 $1.1 Million
Q4 2022 Jan 31, 2023	BUY	$252.44 - $306.72 $871,422 - $1.06 Million	3,452 Added 479.44%	4,172 $1.16 Million
Q3 2022 Nov 04, 2022	SELL	$194.69 - $268.46 $1.09 Million - $1.5 Million	-5,580 Reduced 88.57%	720 $192,000
Q2 2022 Aug 11, 2022	BUY	$187.54 - $223.02 $769,476 - $915,051	4,103 Added 186.75%	6,300 $1.29 Million
Q1 2022 May 06, 2022	BUY	$193.77 - $244.14 $126,338 - $159,179	652 Added 42.2%	2,197 $463,000
Q4 2021 Feb 11, 2022	SELL	$223.92 - $287.77 $26,422 - $33,956	-118 Reduced 7.1%	1,545 $371,000
Q3 2021 Nov 05, 2021	BUY	$282.99 - $369.05 $173,755 - $226,596	614 Added 58.53%	1,663 $471,000
Q2 2021 Aug 03, 2021	BUY	$259.0 - $414.71 $271,691 - $435,030	1,049 New	1,049 $340,000
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $495,618 - $580,645	-2,040 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$236.26 - $355.63 $481,970 - $725,485	2,040 New	2,040 $537,000

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aia Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Aia Group LTD with notifications on news.

Account